Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Illumina Releases International Version of Tertiary Clinical NGS Analysis Software

    Mar 29, 2023, 01:00 AM by User Not Found
    Bio-IT World | Illumina has released Connected Insights, a cloud-based software for tertiary analysis for clinical next-generation sequencing (NGS) data. The software is commercially available in a limited number of countries and in beta testing in the US.
    Full story
  • Genome Citation Service Tracks Genomes Across Research

    Mar 28, 2023, 11:22 AM by User Not Found
    Bio-IT World | Kjiersten Fagnan, chief informatics officer at Lawrence Berkeley National Laboratory’s Joint Genome Institute appears on the Trends from the Trenches podcast to speak with host Stan Gloss of BioTeam about the JGI’s Genome Citation Service, a new offering that connects the broader community with the organization’s data resources and infrastructure.
    Full story
  • AVIA Appoints Scott Cullen, M.D., as EVP of Strategic Innovation and Chief Clinical Officer

    Mar 28, 2023, 10:42 AM by
    Full story
  • Thermo Fisher Introduces HPLC Columns for Protein Charge Variant and AAV Separation

    Mar 28, 2023, 10:40 AM by
    Full story
  • Follow the Money: Recombinase Platform Unlocks Full Potential of Gene Editing, Lead Drug Candidate Clears Neurodegenerative Toxins, More

    Mar 28, 2023, 01:00 AM by User Not Found
    Bio-IT World | Funding pipeline advancement of first-in-class extracellular protein degraders, a proteomics AI-based platform that comprehensively maps the course of a disease, a proprietary computational antibody drug discovery platform that uses machine learning to model antibody-antigen interactions, and more.
    Full story
  • InnovATEBIO Announces First-of-Its-Kind Bioscience Summit

    Mar 27, 2023, 17:05 PM by
    Hello, Thank you for your time. I’m reaching out because I have a story perfect for your publication. The number of technicians needed in the biotechnology industry outnumbers those employed in the field. According to Executive Director of InnovATEBIO National Center for Biotechnology Education, Linnea Fletcher, "If we want to continue to produce vaccines and make other advances, we will need more technicians." On June 26th-27th, InnovATEBIO, a national biotechnology education center, will bring together biotechnology leaders in industry, government, and higher education to explore emerging technologies, build partnerships and showcase how technical education solves rising industry demands. Learn more about the summit here. As a platform dedicated to breaking news on innovative therapeutics and medical technologies, this story would definitely interest your readers. Thanks,
    Full story
  • PacBio Releases Computational Tool for Parsing Pseudogenes

    Mar 24, 2023, 09:11 AM by User Not Found
    Bio-IT World | PacBio last week announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy. The computational tool, named Paraphase, enables variant calling, copy number analysis and phasing by identifying the full gene sequence of each of the haplotypes for all genes and pseudogenes of the same gene family.
    Full story
  • Citeline Finalist CluePoints Show Advanced AI Capabilities

    Mar 23, 2023, 09:41 AM by
    Citeline Finalist CluePoints Show Advanced AI Capabilities RBQM leader shortlisted as a finalist for Citeline Award accolade in The Best Use of Artificial Intelligence in Clinical Trials category
    Full story
  • Forty1's ‘Morphex’ applies innovative Behavioral Algorithm to transform the way people experience business change

    Mar 23, 2023, 09:38 AM by
    Full story
  • Greenphire Launches Research Registry App Allowing Foundations and Advocacy Groups to Better Engage and Support Patient Communities

    Mar 23, 2023, 09:37 AM by
    Registry builds upon the company's robust patient-centric suite of solutions with expanded mobile capabilities and feature functionality depth
    Full story
  • PubHive Upgrades SaaS Platform’s MedDRA Integration to Version 26

    Mar 23, 2023, 09:37 AM by
    Drug safety and pharmacovigilance (DSPV) teams that license access to the PubHive Navigator platform can now access the newest MedDRA version when performing signal evaluation and reporting activities.
    Full story
  • Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

    Mar 23, 2023, 09:24 AM by
    Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.
    Full story
  • Neighborhood Analysis Highlights Role Of Macrophages In ER+ Breast Cancers

    Mar 22, 2023, 09:52 AM by User Not Found
    Bio-IT World | When it comes to breast cancer, the most commonly occurring estrogen receptor-positive (ER+) variety is a poor candidate for treatment with conventional immunotherapies designed to help the patient’s own immune system fight back. Unlike triple-negative breast cancer, ER+ tumors don’t have many infiltrating T cells so potentiating their function alone doesn’t make much of a difference.
    Full story
  • Vaxess Hires Steve Bende, Ph.D., as Chief Strategy Officer

    Mar 22, 2023, 09:18 AM by
    Former global head of new products at Sanofi Pasteur to lead Vaxess’s business and product development strategy
    Full story
  • Alfa Chemistry Renews Supply of Rare Earth Acetates

    Mar 22, 2023, 09:18 AM by
    Full story
  • The Working Principle and Applications of Ion Exchange Resin

    Mar 22, 2023, 09:18 AM by
    Full story
  • CD Formulation Supplies Active Ingredients, Antioxidants, and Chelating Chemicals for Cosmetic Industry

    Mar 22, 2023, 09:17 AM by
    Full story
  • Quantitative Analysis of ADC Components - Ligand Binding Assay (LBA) and LC-MS/MS

    Mar 22, 2023, 09:16 AM by
    There are both large and small ADC molecules. A variety of biological analysis methods and platforms are needed to analyze the diversity of ADCs.
    Full story
  • Survey Reveals Older Adults Eager to Get Ahead of Alzheimer's and Other Dementias; Industry Lags

    Mar 22, 2023, 09:15 AM by
    92% of participants want to know about Alzheimer’s early according to new Linus Health report
    Full story
  • Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs

    Mar 22, 2023, 09:15 AM by
    Driving more complete decisions for biopharmaceutical companies with modern digital pathology
    Full story
  • «
  • 91
  • 92
  • 93
  • 94
  • 95 (current)
  • 96
  • 97
  • 98
  • 99
  • 100
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy